TrialSpark acquires immunodermatology portfolio and creates Libertas Bio
TrialSpark has announced the formation of Libertas Bio following the acquisition of a majority position…
November 30, 2022 - 3 minutes
Skin disease
New Replay HSV gene therapy company Telaria to focus on skin diseases
Replay has announced the launch of Telaria, a herpes simplex virus (HSV) gene therapy company…
November 21, 2022 - 3 minutes
A new treatment for tackling epidermolysis bullosa
By Jordi Casals, president, EMEA, Amryt Pharma Epidermolysis bullosa (EB), sometimes described as “the worst…
November 14, 2022 - 3 minutes
Prurigo nodularis treatment recommended for EU approval
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a…
November 11, 2022 - 3 minutes
Incyte to acquire Medicxi-backed Villaris Therapeutics to tackle vitiligo
Incyte has entered into an agreement to acquire Villaris Therapeutics, an asset-centric biopharmaceutical company seeded…
October 3, 2022 - 3 minutes
Treatment for adults with chronic skin condition approved by FDA
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of…
September 29, 2022 - 4 minutes
Kamari Pharma raises $8M in investment for development of drugs for skin diseases
An $8 million investment has been raised by Kamari Pharma following investment from the Guangzhou-Israel…
September 19, 2022 - 3 minutes
Regeneron and Sanofi announce published trial results in children with dermatitis
Positive results from a phase 3 trial in children aged 6 months to five years…
September 16, 2022 - 3 minutes
Ilya Pharma partners with US Defense Department for wound healing drug
A drug to accelerate wound healing and reduced scar volume has had a major breakthrough…
September 13, 2022 - 3 minutes
Treatment for adults with moderate to severe psoriasis approved by FDA
A treatment for adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or…
September 12, 2022 - 3 minutes
Lutris Pharma radiation trial brings positive results for breast cancer patients
Top line results from a clinical trial treating breast cancer patients with radiation dermatitis (RD)…
September 8, 2022 - 4 minutes
Psoriasis pustules disappear in over half of patients using Boehringer Ingelheim drug
More than half of patients treated for psoriasis with an intravenous injection showed no visible…
September 2, 2022 - 2 minutes
